Logo image of BRIA

BRILLIA INC-A (BRIA) Stock Fundamental Analysis

NYSEARCA:BRIA - NYSE Arca - KYG1645N1016 - Common Stock - Currency: USD

2.9019  -0.03 (-0.96%)

Fundamental Rating

1

BRIA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of BRIA have multiple concerns. BRIA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BRIA had positive earnings in the past year.
In the past year BRIA has reported a negative cash flow from operations.
BRIA Yearly Net Income VS EBIT VS OCF VS FCFBRIA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2M 4M 6M 8M 10M

1.2 Ratios

The last Return On Invested Capital (49.37%) for BRIA is well below the 3 year average (55.82%), which needs to be investigated, but indicates that BRIA had better years and this may not be a problem.
Industry RankSector Rank
ROA 11.94%
ROE 43.85%
ROIC 49.37%
ROA(3y)16.06%
ROA(5y)N/A
ROE(3y)52.81%
ROE(5y)N/A
ROIC(3y)55.82%
ROIC(5y)N/A
BRIA Yearly ROA, ROE, ROICBRIA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 20 40 60

1.3 Margins

Industry RankSector Rank
OM 7.67%
PM (TTM) 5.64%
GM 44.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BRIA Yearly Profit, Operating, Gross MarginsBRIA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRIA is creating value.
Compared to 1 year ago, BRIA has about the same amount of shares outstanding.
The debt/assets ratio for BRIA is higher compared to a year ago.
BRIA Yearly Shares OutstandingBRIA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
BRIA Yearly Total Debt VS Total AssetsBRIA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

BRIA has an Altman-Z score of 6.10. This indicates that BRIA is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.01 indicates that BRIA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 6.1
ROIC/WACC4.88
WACC10.12%
BRIA Yearly LT Debt VS Equity VS FCFBRIA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

BRIA has a Current Ratio of 1.33. This is a normal value and indicates that BRIA is financially healthy and should not expect problems in meeting its short term obligations.
BRIA has a Quick Ratio of 1.33. This is a bad value and indicates that BRIA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.96
BRIA Yearly Current Assets VS Current LiabilitesBRIA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

BRIA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.65%.
The Revenue has grown by 8.03% in the past year. This is quite good.
EPS 1Y (TTM)-24.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.65%
Revenue 1Y (TTM)8.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRIA Yearly Revenue VS EstimatesBRIA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 20M 40M 60M
BRIA Yearly EPS VS EstimatesBRIA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BRIA is valuated quite expensively with a Price/Earnings ratio of 29.02.
Compared to an average S&P500 Price/Earnings ratio of 29.35, BRIA is valued at the same level.
Industry RankSector Rank
PE 29.02
Fwd PE N/A
BRIA Price Earnings VS Forward Price EarningsBRIA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.39
BRIA Per share dataBRIA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BRIA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRILLIA INC-A

NYSEARCA:BRIA (3/7/2025, 8:08:26 PM)

2.9019

-0.03 (-0.96%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners90%
Ins Owner ChangeN/A
Market Cap88.86M
AnalystsN/A
Price TargetN/A
Short Float %0.34%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 29.02
Fwd PE N/A
P/S 1.59
P/FCF N/A
P/OCF N/A
P/B 12.39
P/tB 12.39
EV/EBITDA 19.39
EPS(TTM)0.1
EY3.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS1.82
BVpS0.23
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.94%
ROE 43.85%
ROCE 59.59%
ROIC 49.37%
ROICexc 279.42%
ROICexgc 279.42%
OM 7.67%
PM (TTM) 5.64%
GM 44.89%
FCFM N/A
ROA(3y)16.06%
ROA(5y)N/A
ROE(3y)52.81%
ROE(5y)N/A
ROIC(3y)55.82%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)67.27%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.12
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.01
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.96
Altman-Z 6.1
F-Score3
WACC10.12%
ROIC/WACC4.88
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-101.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-101.61%
OCF growth 3YN/A
OCF growth 5YN/A